|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/24 | (2006.01) |
| A61K2039/545 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K 16/244 | (2013.01) | ||
| A61P 37/06 | (2006.01) | ||
| A61P 37/06 | (2018.01) | ||
| C07K2317/21 | (2013.01) |
| (11) | Number of the document | 4244252 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22769624.2 |
| Date of filing the European patent application | 2022-08-26 | |
| (97) | Date of publication of the European application | 2023-09-20 |
| (45) | Date of publication and mention of the grant of the patent | 2024-05-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2022/073766 |
| Date | 2022-08-26 |
| (87) | Number | WO 2023/025932 |
| Date | 2023-03-02 |
| (30) | Number | Date | Country code |
| 202163237630 P | 2021-08-27 | US | |
| 202263364734 P | 2022-05-16 | US |
| (72) |
SADIQ, Muhammad Waqas , SE
LOZANO, Eulalia Jimenez , ES
|
| (73) |
MedImmune Limited ,
1 Francis Crick Avenue
Cambridge Biomedical Campus, Cambridge CB2 0AA,
GB
|
| (54) | TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH AN ANTI-INTERLEUKIN-33 ANTIBODY |
| TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH AN ANTI-INTERLEUKIN-33 ANTIBODY |